You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Tailorable Accurate Blood Simulant (TABS)
SBC: Infoscitex Corporation Topic: OSD10H01Many blood simulants that are currently available for medical training to teach and practice hemorrhage-handling skills lack the ability approximate real blood in many aspects. In order to provide the best training, the blood simulant needs to mimic the
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Advanced Blood Simulant for Simulation Based Medical Trauma Training
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD10H01The aim of this proposal is to develop an advanced blood simulant to replace current simulants used in combat medical training. A successful blood simulant will exhibit a caking/clotting response in the presence of simulated hemostatic agents while accur
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Spatiotemporally Controlled Delivery System that Promotes Functional Tissue Regeneration
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD10H03As advances in battlefield care have led to increased survival, improved strategies for treating devastating, multi-tissue injuries are needed. Historical regenerative medicine strategies to restore function to damaged tissues have failed to fulfill the
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Nano-Structured Spatiotemporally Controlled Delivery System that Promotes Functional Tissue Regeneration
SBC: Infoscitex Corporation Topic: OSD10H03There is a substantial clinical need for regenerative therapies that effectively restore function to damaged tissues. For many tissues, autograft remains the clinical standard despite the limited volume available, associated patient morbidity and the resu
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Technologies for Treating Cartilage Tissue Loss Following Traumatic Injury
SBC: Spheringenics, Inc. Topic: OSD10H04Regeneration of cartilage and cartilage repair are challenging due to limited cellularity of the tissue and the failure of allografts and tissue engineered cartilage constructs to integrate with host tissue. To overcome this limitation, many surgeons are
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
The Development of an Injectable Cartilage Regeneration Construct
SBC: LUNA INNOVATIONS INCORPORATED Topic: OSD10H04Craniofacial injuries to warfighters are on the rise as improvements to body armor have caused the unprotected face of the soldier to become a target for attack. These injuries are often associated with severe trauma to the underlying cartilage structure.
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Cell-based Cartilage Tissue Matrix for Repair of Focal Defects in the CMF Cartilages
SBC: Physical Optics Corporation Topic: OSD10H04Head and neck surgeons are often challenged by the paucity of autografts to reconstruct large CMF defects; a grafting technology for replacing and regenerating lost tissue is needed. To address this OSD need, Physical Optics Corporation (POC) proposes to
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Technologies for Treating Cartilage Tissue Loss Following Traumatic Injury
SBC: StemRD, Inc. Topic: OSD10H04Regenerative cell therapy using adult mesenchymal stem cells (MSCs) offers great potential to therapeutic cartilage repair. However, the current MSC chondrogenesis method of using TGF-beta is inefficient and assumes fibrocartilage-like features and hyper
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Deployable Automated Analgesia and Anesthesia System
SBC: VIVONICS INC Topic: OSD10H05An automated, closed loop system for administration of analgesic and anesthetic medication to patients is proposed. Even with vigilant, trained personnel, infusion rates of propofol and other analgesic/anesthetic drugs can depart from their optimum rates,
SBIR Phase I 2011 Department of DefenseDefense Health Agency -
Deployable Remotely Enabled Analgesia Management System
SBC: Etiometry Inc. Topic: OSD10H05Sterling Point Research has assembled an interdisciplinary team composed of researchers from Children"s Hospital Boston and Boston University, an anesthesiologist, and a former U.S. Army medic to develop a Deployable Remotely Enabled Analgesia Management
SBIR Phase I 2011 Department of DefenseDefense Health Agency